BD-PT5840

WISP-3 Rabbit Polyclonal Antibody

WNT1-inducible-signaling pathway protein 3 (WISP-3) (CCN family member 6)

常规抗体

WISP3 CCN6 UNQ462/PRO790/PRO956

WNT1-inducible-signaling pathway protein 3 (WISP-3) (CCN family member 6)

WB

Human,Rat,Mouse

1 mg/ml

Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% New type preservative N.

8838

http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene&term=8838

O95389

http://www.uniprot.org/uniprotkb/O95389/entry

327743

D3Z5L9

http://www.uniprot.org/uniprot/D3Z5L9

The antiserum was produced against synthesized peptide derived from the N-terminal region of human WISP3. AA range:1-50

The antibody detects endogenous WISP-3

WB 1:500-2000, ELISA 1:10000-20000

55kD

-20°C/1 year

Polyclonal, Rabbit,IgG

This gene encodes a member of the WNT1 inducible signaling pathway (WISP) protein subfamily, which belongs to the connective tissue growth factor (CTGF) family. WNT1 is a member of a family of cysteine-rich, glycosylated signaling proteins that mediate diverse developmental processes. The CTGF family members are characterized by four conserved cysteine-rich domains: insulin-like growth factor-binding domain, von Willebrand factor type C module, thrombospondin domain and C-terminal cystine knot-like domain. This gene is overexpressed in colon tumors. It may be downstream in the WNT1 signaling pathway that is relevant to malignant transformation. Mutations of this gene are associated with progressive pseudorheumatoid dysplasia, an autosomal recessive skeletal disorder, indicating that the gene is essential for normal postnatal skeletal growth and cartilage homeostasis. Multiple

Predominant expression in adult kidney and testis and fetal kidney. Weaker expression found in placenta, ovary, prostate and small intestine (PubMed:9843955, PubMed:10471507). Also expressed in skeletally-derived cells such as synoviocytes and articular cartilage chondrocytes (PubMed:10471507).

Secreted . Mitochondrion . Associated with membranes. .

disease:Defects in WISP3 are the cause of progressive pseudorheumatoid arthropathy of childhood (PPAC) [MIM:208230]. PPAC is an autosomal recessive disorder characterized by stiffness and swelling of joints, motor weakness and joint contractures. Signs and symptoms of the disease develop typically between three and eight years of age. This progressive disease is a primary disorder of articular cartilage with continued cartilage loss and destructive bone changes with aging.,function:Appears to be required for normal postnatal skeletal growth and cartilage homeostasis.,similarity:Belongs to the CCN family.,similarity:Contains 1 CTCK (C-terminal cystine knot-like) domain.,similarity:Contains 1 IGFBP N-terminal domain.,similarity:Contains 1 TSP type-1 domain.,tissue specificity:Predominant expression in adult kidney and testis and fetal kidney. Weaker expression found in placenta, ovary, prostate and small intestine. Also expressed in skeletally-derived cells such as synoviocytes and articular cartilage chondrocytes.,

现货

The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.